Company intelligence / Profile preview

Logix Biosciences

Monterey, California, United Stateslogixbiosciences.com ↗
Ownership
Private
Employees
~44
Development stage
Preclinical
01

Overview

Logix Biosciences is developing a pipeline of precision therapeutics focused on nasal immune modulation to prevent and treat allergies, infectious diseases, antimicrobial resistance, and related conditions. Their lead candidate LGX 242 is in preclinical development targeting allergies with broader potential applications. The company has demonstrated proof-of-concept with non-drug OTC nasal sprays but is advancing drug candidates through preclinical stages. They recently entered into an agreement with Mayo Clinic to advance their therapeutic programs for allergy relief, mutating infectious diseases, and antimicrobial resistance[2].

Therapeutic areas
PulmonologyImmunologyInfectious Diseases
Modalities
Non-steroidal immune modulatorsNasal sprays (non-drug OTC and drug candidates)
Industry
Biotech
02

Drug pipeline

2 assets

LGX 242

Preclinical

1 more asset in the full pipeline.

03

Partnerships

Mayo Clinic (agreement to advance development of therapeutics for allergy relief and infectious disease)[2]

Beyond the preview

Go deeper on Logix Biosciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Logix Biosciences.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call